| Leanne Calder, | |
|
39614 N Mill Creek Ct, Anthem, AZ 85086-2354 | |
| (623) 551-1031 | |
| (623) 551-4924 |
| Full Name | Leanne Calder |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 39614 N Mill Creek Ct, Anthem, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366855496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14017 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Leanne Calder, 39614 N Mill Creek Ct, Anthem, AZ 85086-2354 Ph: (623) 551-4885 | Leanne Calder, 39614 N Mill Creek Ct, Anthem, AZ 85086-2354 Ph: (623) 551-1031 |
News Archive
One to five percent of college students develop infectious mononucleosis each year, and about 10 percent are diagnosed six months later with chronic fatigue syndrome - a complex condition involving severe fatigue coupled with disabling cognitive and musculoskeletal symptoms.
The largest study ever to investigate the genetics of osteoporosis and fracture risk determined that only two examined factors - bone mineral density and muscle strength - play a potentially causal role in the risk of suffering osteoporotic fracture, a major health problem affecting more than 9 million people worldwide very year.
In a new JAMA editorial, a Boston University School of Public Health (BUSPH) researcher and a health research journalist outline common ways that media, governments, and industry and academic public relations press releases have incompletely and misleadingly reported coronavirus research, and how they can do better.
Castlight Health, the first company to empower consumers with information to effectively navigate the health care system, today announced that it has raised $60 million in Series C funding. The round included new investors Morgan Stanley Investment Management, The Wellcome Trust, U.S. Venture Partners, and Cleveland Clinic, as well as existing investors Maverick Capital, Oak Investment Partners and Venrock.
Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill leukemia cells much more effectively when combined than when the drugs are administered individually.
› Verified 7 days ago
Curtis Arno Mortensen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3610 W Anthem Way, Anthem, AZ 85086 Phone: 623-551-4299 | |
Dr. Jennifer Flynn, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3655 W Anthem Way, Anthem, AZ 85086 Phone: 623-745-3805 | |
Dr. Benjamin Paul Sechena, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3610 W Anthem Way, Anthem, AZ 85086 Phone: 623-551-4299 | |
Robin Lee Carter, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39510 N Gavilan Peak Pkwy, Anthem, AZ 85086 Phone: 623-551-1031 Fax: 623-551-4924 | |
George Langford, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3655 W Anthem Way, Anthem, AZ 85086 Phone: 623-551-0300 Fax: 623-551-0220 | |
Kayla King Brawley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3610 W Anthem Way, Anthem, AZ 85086 Phone: 623-551-4299 | |
Alisa Hirschberg, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3655 W Anthem Way, Anthem, AZ 85086 Phone: 623-551-0300 |